201 related articles for article (PubMed ID: 34963495)
21. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
Chen J; Sun MX; Hua YQ; Cai ZD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
[TBL] [Abstract][Full Text] [Related]
23. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma.
Jung ST; Moon ES; Seo HY; Kim JS; Kim GJ; Kim YK
Orthopedics; 2005 Aug; 28(8):755-60. PubMed ID: 16119739
[TBL] [Abstract][Full Text] [Related]
24. The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma.
Kaya M; Wada T; Nagoya S; Sasaki M; Matsumura T; Yamashita T
J Bone Joint Surg Br; 2009 Jun; 91(6):784-8. PubMed ID: 19483233
[TBL] [Abstract][Full Text] [Related]
25. Letter regarding Chen et al. entitled "a systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma".
Liu LH; Li H; Xiao T
Tumour Biol; 2014 Sep; 35(9):8535. PubMed ID: 25168371
[No Abstract] [Full Text] [Related]
26. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
Zhu H; Cai H; Tang M; Tang J
Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
[TBL] [Abstract][Full Text] [Related]
27. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
28. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
29. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
30. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.
Hu F; Shang XF; Wang W; Jiang W; Fang C; Tan D; Zhou HC
Int J Exp Pathol; 2016 Feb; 97(1):86-92. PubMed ID: 27028305
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
33. Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Han I; Lee MR; Nam KW; Oh JH; Moon KC; Kim HS
Clin Orthop Relat Res; 2008 Sep; 466(9):2107-13. PubMed ID: 18563508
[TBL] [Abstract][Full Text] [Related]
34. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.
Liu Y; Wu Y; Gu S; Sun Z; Rui Y; Wang J; Lu Y; Li H; Xu K; Sheng P
Diagn Pathol; 2014 Aug; 9():140. PubMed ID: 25112408
[TBL] [Abstract][Full Text] [Related]
36. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Zhou J; Liu T; Wang W
Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
40. P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.
Tang Y; Yang C; Guo Z; Fu Y; Yu X; Liu B; Zhou H; Wang J; Li W; Pang Q
Medicine (Baltimore); 2017 May; 96(19):e6714. PubMed ID: 28489748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
